These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19448205)

  • 1. New therapeutic agents for diabetes mellitus: implications for anesthetic management.
    Chen D; Lee SL; Peterfreund RA
    Anesth Analg; 2009 Jun; 108(6):1803-10. PubMed ID: 19448205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond.
    Inzucchi SE; McGuire DK
    Circulation; 2008 Jan; 117(4):574-84. PubMed ID: 18227398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining incretin hormone pathways for novel therapies.
    Wideman RD; Kieffer TJ
    Trends Endocrinol Metab; 2009 Aug; 20(6):280-6. PubMed ID: 19595611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antidiabetics and the incretin system].
    Høibraaten E; Folkersen J
    Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1985. PubMed ID: 18787580
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-insulin treatments for diabetes.
    Angueira E
    Am J Ther; 2013; 20(4):377-84. PubMed ID: 23838634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging therapies: an overview of incretin-based therapy in the management of type 2 diabetes.
    Pratley RE
    J Am Acad Nurse Pract; 2008 Nov; 20 Suppl 1():7-11. PubMed ID: 19402254
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic modifications of hormones to improve their therapeutic potential for diabetes management.
    Garber AJ
    Diabetes Obes Metab; 2005 Nov; 7(6):666-74. PubMed ID: 16219010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications.
    Roth JD; Maier H; Chen S; Roland BL
    Arch Neurol; 2009 Mar; 66(3):306-10. PubMed ID: 19273748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating diabetes with incretin hormones - clinical experience.
    Handelsman Y
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):897-903. PubMed ID: 18552752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the incretin system in type 2 diabetes mellitus.
    Potenza M; Rayfield EJ
    Mt Sinai J Med; 2009 Jun; 76(3):244-56. PubMed ID: 19421968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatogenic diabetes--the current concepts of its pathophysiology and therapy].
    Siegel EG; Gallwitz B; Schmidt WE; Fölsch UR
    Dtsch Med Wochenschr; 1999 Dec; 124(50):1530-5. PubMed ID: 10633781
    [No Abstract]   [Full Text] [Related]  

  • 13. Dietary supplements in the management of diabetes: potential risks and benefits.
    Geil P; Shane-McWhorter L
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S59-65. PubMed ID: 18358258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?
    Giugliano D; Standl E; Vilsbøll T; Betteridge J; Bonadonna R; Campbell IW; Schernthaner GH; Staels B; Trichopoulou A; Farinaro E
    Acta Diabetol; 2009 Sep; 46(3):173-81. PubMed ID: 19543848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of diabetes mellitus. New developments and hopes].
    Verspohl EJ
    Med Monatsschr Pharm; 2005 Jun; 28(6):193-202; quiz 203. PubMed ID: 15960421
    [No Abstract]   [Full Text] [Related]  

  • 16. Leapin' lizards: Amylin targets diabetes and obesity via incretins.
    Wolfson W
    Chem Biol; 2007 Mar; 14(3):235-6. PubMed ID: 17379135
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1.
    Riddle MC; Drucker DJ
    Diabetes Care; 2006 Feb; 29(2):435-49. PubMed ID: 16443905
    [No Abstract]   [Full Text] [Related]  

  • 18. New insulin analogues and insulin delivery devices for the perioperative management of diabetic patients.
    Ferrari LR
    Curr Opin Anaesthesiol; 2008 Jun; 21(3):401-5. PubMed ID: 18458562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From lizard to lab to you.
    Gebel E
    Diabetes Forecast; 2009 Dec; 62(12):46-8. PubMed ID: 20043419
    [No Abstract]   [Full Text] [Related]  

  • 20. Future therapy of diabetes mellitus.
    Takei I; Kasatani T
    Biomed Pharmacother; 2004 Dec; 58(10):578-81. PubMed ID: 15589066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.